B D Potts

1.1k total citations
13 papers, 168 citations indexed

About

B D Potts is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, B D Potts has authored 13 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in B D Potts's work include Epilepsy research and treatment (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). B D Potts is often cited by papers focused on Epilepsy research and treatment (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). B D Potts collaborates with scholars based in United States and United Kingdom. B D Potts's co-authors include C. John Parli, Jingqi Bao, R Hahn, Brian MacDonald, Paul J. Simpson, J. David Leander, David W. Robertson, Mary Vore, Carlos A. Martín and Winston S. Marshall and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Clinical Chemistry.

In The Last Decade

B D Potts

13 papers receiving 166 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B D Potts United States 7 50 42 38 35 27 13 168
Kelly-Ann S. Schlegel 3 32 0.6× 38 0.9× 145 3.8× 21 0.6× 45 1.7× 3 306
O Christ Switzerland 9 22 0.4× 50 1.2× 65 1.7× 83 2.4× 52 1.9× 15 331
M. van der Graaff Netherlands 9 19 0.4× 37 0.9× 19 0.5× 22 0.6× 81 3.0× 24 232
Richard N. Booher United States 8 19 0.4× 148 3.5× 67 1.8× 50 1.4× 33 1.2× 11 329
Karen L Locker United Kingdom 7 91 1.8× 124 3.0× 24 0.6× 77 2.2× 21 0.8× 8 296
Brian Boucher United States 5 126 2.5× 166 4.0× 21 0.6× 26 0.7× 13 0.5× 5 369
Peter E. Haroldsen United States 12 132 2.6× 168 4.0× 20 0.5× 62 1.8× 24 0.9× 20 370
L Avois Switzerland 8 82 1.6× 88 2.1× 50 1.3× 5 0.1× 18 0.7× 9 459
Baiba I. Norton United States 10 17 0.3× 108 2.6× 21 0.6× 36 1.0× 78 2.9× 19 368
R.H. Connamacher United States 6 19 0.4× 113 2.7× 42 1.1× 83 2.4× 14 0.5× 9 297

Countries citing papers authored by B D Potts

Since Specialization
Citations

This map shows the geographic impact of B D Potts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B D Potts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B D Potts more than expected).

Fields of papers citing papers by B D Potts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B D Potts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B D Potts. The network helps show where B D Potts may publish in the future.

Co-authorship network of co-authors of B D Potts

This figure shows the co-authorship network connecting the top 25 collaborators of B D Potts. A scholar is included among the top collaborators of B D Potts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B D Potts. B D Potts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bao, Jingqi & B D Potts. (2001). Quantitative determination of olanzapine in rat brain tissue by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 752(1). 61–67. 20 indexed citations
2.
Leander, J. David, C. John Parli, B D Potts, & David Lodge. (1992). Relation of Plasma and Brain Concentrations of the Anticonvulsant Ameltolide to Its Pharmacologic Effects. Epilepsia. 33(4). 696–704. 2 indexed citations
3.
Hahn, R, Brian MacDonald, Elizabeth N. Morgan, et al.. (1992). Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 979–989. 18 indexed citations
4.
Potts, B D & C. John Parli. (1992). Analysis of the Enantiomers of Fluoxetine and Norfluoxetine in Plasma and Tissue Using Chiral Derivatization and Normal-Phase Liquid Chromatography. Journal of Liquid Chromatography. 15(4). 665–681. 52 indexed citations
5.
Robertson, David W., et al.. (1991). Synthesis and pharmacological evaluation of a major metabolite of ameltolide, a potent anticonvulsant. Journal of Medicinal Chemistry. 34(4). 1253–1257. 6 indexed citations
6.
Hahn, R, Brian MacDonald, Paul J. Simpson, B D Potts, & C. John Parli. (1990). Antagonism of leukotriene B4 receptors does not limit canine myocardial infarct size.. Journal of Pharmacology and Experimental Therapeutics. 253(1). 58–66. 25 indexed citations
7.
Martin, Catherine, et al.. (1989). Methylphenidate Plasma Concentrations in Chronically and Acutely Treated Latency-Age Children. Pharmacology. 39(1). 46–49. 1 indexed citations
8.
Potts, B D, et al.. (1989). Metabolism, disposition, and pharmacokinetics of a potent anticonvulsant, 4-amino-N-(2,6-dimethylphenyl)benzamide (LY201116), in rats.. Drug Metabolism and Disposition. 17(6). 656–661. 10 indexed citations
9.
10.
Robertson, David W., et al.. (1987). Discovery and anticonvulsant activity of the potent metabolic inhibitor 4-amino-N-(2,6-dimethylphenyl)-3,5-dimethylbenzamide. Journal of Medicinal Chemistry. 30(10). 1742–1746. 13 indexed citations
11.
Straub, Kenneth, et al.. (1986). Pharmacokinetics, metabolism, and disposition of 6-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepine (SK&F 86466) in rats and dogs.. Drug Metabolism and Disposition. 14(5). 540–548. 2 indexed citations
12.
Straub, Kenneth, et al.. (1986). Pharmacokinetics, metabolism, and disposition of 6-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepine (SK&F 86466) in rats and dogs.. PubMed. 14(5). 540–8. 6 indexed citations
13.
Potts, B D, Carlos A. Martín, & Mary Vore. (1984). Gas-chromatographic quantification of methylphenidate in plasma with use of solid-phase extraction and nitrogen-sensitive detection.. Clinical Chemistry. 30(8). 1374–1377. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly-Ann S. Schlegel Breakdown of academic impact, for papers by O Christ Breakdown of academic impact, for papers by M. van der Graaff Breakdown of academic impact, for papers by Richard N. Booher Breakdown of academic impact, for papers by Karen L Locker Breakdown of academic impact, for papers by Brian Boucher Breakdown of academic impact, for papers by Peter E. Haroldsen Breakdown of academic impact, for papers by L Avois Breakdown of academic impact, for papers by Baiba I. Norton Breakdown of academic impact, for papers by R.H. Connamacher
Rankless by CCL
2026